MRK vs TMO
By Alex · Tickerpine
Merck & Co., Inc. vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TMO |
|---|---|---|
| Price | $156.45 | $628.15 |
| Market cap | $385.99B | $232.26B |
| P/E ratio | 120.3 | 33.8 |
| ROE | 6.96% | 13.51% |
| Profit margin | 4.77% | 15.04% |
| Revenue growth | 5.10% | 10.50% |
| Dividend yield | 2.26% | 0.30% |
| Beta | 0.21 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TMO in plain English
- MRK is the bigger company — about 1.7× the market cap of TMO.
- TMO is cheaper on earnings (P/E 33.8 vs 120.3).
- TMO earns a higher return on equity (14% vs 7%).
- TMO is growing revenue faster (10% vs 5%).
- MRK has the higher dividend yield (2.26% vs 0.30%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.